Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern.
Saved in:
| Title: | Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern. |
|---|---|
| Authors: | Cohen-Dvashi H; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Weinstein J; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel., Katz M; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Eilon-Ashkenazy M; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Mor Y; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Shimon A; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Achdout H; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Tamir H; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Israely T; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Strobelt R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel., Shemesh M; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel., Stoler-Barak L; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel., Shulman Z; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel., Paran N; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Fleishman SJ; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel., Diskin R; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel. |
| Source: | IScience [iScience] 2022 Oct 21; Vol. 25 (10), pp. 105193. Date of Electronic Publication: 2022 Sep 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36188189 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cohen-Dvashi+H%22">Cohen-Dvashi H</searchLink>; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Weinstein+J%22">Weinstein J</searchLink>; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Katz+M%22">Katz M</searchLink>; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Eilon-Ashkenazy+M%22">Eilon-Ashkenazy M</searchLink>; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Mor+Y%22">Mor Y</searchLink>; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Shimon+A%22">Shimon A</searchLink>; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Achdout+H%22">Achdout H</searchLink>; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel.<br /><searchLink fieldCode="AU" term="%22Tamir+H%22">Tamir H</searchLink>; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel.<br /><searchLink fieldCode="AU" term="%22Israely+T%22">Israely T</searchLink>; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel.<br /><searchLink fieldCode="AU" term="%22Strobelt+R%22">Strobelt R</searchLink>; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Shemesh+M%22">Shemesh M</searchLink>; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Stoler-Barak+L%22">Stoler-Barak L</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Shulman+Z%22">Shulman Z</searchLink>; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Paran+N%22">Paran N</searchLink>; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel.<br /><searchLink fieldCode="AU" term="%22Fleishman+SJ%22">Fleishman SJ</searchLink>; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.<br /><searchLink fieldCode="AU" term="%22Diskin+R%22">Diskin R</searchLink>; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101724038%22">IScience</searchLink> [iScience] 2022 Oct 21; Vol. 25 (10), pp. 105193. <i>Date of Electronic Publication: </i>2022 Sep 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101724038 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-0042 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225890042%22">25890042 </searchLink><i>NLM ISO Abbreviation: </i>iScience <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36188189 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.isci.2022.105193 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 105193 Titles: – TitleFull: Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cohen-Dvashi H – PersonEntity: Name: NameFull: Weinstein J – PersonEntity: Name: NameFull: Katz M – PersonEntity: Name: NameFull: Eilon-Ashkenazy M – PersonEntity: Name: NameFull: Mor Y – PersonEntity: Name: NameFull: Shimon A – PersonEntity: Name: NameFull: Achdout H – PersonEntity: Name: NameFull: Tamir H – PersonEntity: Name: NameFull: Israely T – PersonEntity: Name: NameFull: Strobelt R – PersonEntity: Name: NameFull: Shemesh M – PersonEntity: Name: NameFull: Stoler-Barak L – PersonEntity: Name: NameFull: Shulman Z – PersonEntity: Name: NameFull: Paran N – PersonEntity: Name: NameFull: Fleishman SJ – PersonEntity: Name: NameFull: Diskin R IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 10 Text: 2022 Oct 21 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2589-0042 Numbering: – Type: volume Value: 25 – Type: issue Value: 10 Titles: – TitleFull: IScience Type: main |
| ResultId | 1 |